<?xml version="1.0" encoding="UTF-8"?>
<ref id="B60-biomedicines-08-00060">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vähä-Koskela</surname>
    <given-names>M.J.V.</given-names>
   </name>
   <name>
    <surname>Kallio</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Jansson</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Heikkilä</surname>
    <given-names>J.E.</given-names>
   </name>
   <name>
    <surname>Zakhartchenko</surname>
    <given-names>V.A.</given-names>
   </name>
   <name>
    <surname>Kallajoki</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Kähäri</surname>
    <given-names>V.-M.</given-names>
   </name>
   <name>
    <surname>Hinkkanen</surname>
    <given-names>A.E.</given-names>
   </name>
  </person-group>
  <article-title>Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice</article-title>
  <source>Cancer Res.</source>
  <year>2006</year>
  <volume>66</volume>
  <fpage>7185</fpage>
  <lpage>7194</lpage>
  <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2214</pub-id>
  <pub-id pub-id-type="pmid">16849565</pub-id>
 </element-citation>
</ref>
